GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Long-Term Debt

Acepodia (ROCO:6976) Long-Term Debt : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Long-Term Debt?

Acepodia's Long-Term Debt for the quarter that ended in Jun. 2024 was NT$0.00 Mil.

Acepodia Long-Term Debt Historical Data

The historical data trend for Acepodia's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Long-Term Debt Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Long-Term Debt
- - - -

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Long-Term Debt Get a 7-Day Free Trial - - - - -

Acepodia  (ROCO:6976) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Acepodia Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Acepodia's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Long-Term Debt
Comparable Companies
ROCO:4174 ROCO:6617 ROCO:4162 ROCO:6712 ROCO:4147 ROCO:6586 ROCO:6547 ROCO:6919 TPE:4142 ROCO:4157 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Website
https://www.acepodia.com
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines